Prelude Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$59.5K	Sell	16,004 -2,823	-15%	-$19.5K	﹤0.01%	1112
2025 Q4	$154K	Buy	+18,827	New	+$139K	0.01%	1118
2025 Q3	–	Sell	-13,096	Closed	-$106K	–	1279
2025 Q2	$106K	Sell	13,096 -10,871	-45%	-$73.3K	0.01%	911
2025 Q1	$169K	Buy	23,967 +9,381	+64%	+$58.3K	0.02%	977
2024 Q4	$108K	Sell	14,586 -12,918	-47%	-$82.5K	0.01%	1088
2024 Q3	$136K	Buy	+27,504	New	+$144K	0.01%	1124
2024 Q1	–	Sell	-22,745	Closed	-$141K	–	1462
2023 Q4	$141K	Buy	+22,745	New	+$158K	0.01%	998
2023 Q2	–	Sell	-21,295	Closed	-$80.4K	–	1269
2023 Q1	$80.4K	Buy	+21,295	New	+$119K	0.01%	972
2019 Q4	–	Sell	-1,640	Closed	-$18K	–	2195
2019 Q3	$18K	Buy	1,640 +951	+138%	+$10.4K	﹤0.01%	1408
2019 Q2	$6K	Buy	+689	New	+$6.96K	﹤0.01%	1500
2017 Q3	–	Sell	-2,300	Closed	-$34K	–	1807
2017 Q2	$34K	Buy	+2,300	New	+$32K	﹤0.01%	1116
2017 Q1	–	Sell	-400	Closed	-$6K	–	1651
2016 Q4	$6K	Buy	+400	New	+$5.54K	﹤0.01%	1419
2015 Q4	–	Sell	-200	Closed	-$2K	–	1593
2015 Q3	$2K	Sell	200 -1,400	-88%	-$18.5K	﹤0.01%	1432
2015 Q2	$23K	Sell	1,600 -1,300	-45%	-$18.8K	﹤0.01%	1325
2015 Q1	$40K	Buy	+2,900	New	+$40.1K	0.01%	1434
2014 Q3	–	Sell	-15,300	Closed	-$191K	–	2020
2014 Q2	$191K	Buy	15,300 +900	+6%	+$10.6K	0.03%	762
2014 Q1	$161K	Sell	14,400 -5,614	-28%	-$61.6K	0.03%	810
2013 Q4	$243K	Buy	20,014 +754	+4%	+$9K	0.05%	569
2013 Q3	$235K	Buy	+19,260	New	+$269K	0.05%	491

Other funds holding LFCR